Long-term Follow-up Study of Patients Receiving CAR-T Cells
Recruiting
Observational Study
Chronic Lymphocytic Leukemia
Lymphomas Non-Hodgkin's B-Cell
Lymphoma, Small Lymphocytic
Mantle Cell Lymphoma
Central Nervous System Lymphoma
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Burkitt Lymphoma
Multiple Myeloma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Medical College of Wisconsin · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This protocol is designed as a long-term follow-up study of participants who will receive CAR-T cells as part of a clinical trial at the Medical College of Wisconsin/ Froedtert Hospital. The clinical trials include the following:
Phase 1 Study of CAR-20/19-T Cells in Patients with Relapsed Refractory B Cell Malignancies (NCT03019055); Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refrac…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All participants who enrolled in a CAR-T study at Froedtert Hospital \& the Medical College of Wisconsin.
Exclusion Criteria:
* There are no exclusion criteria for this study.
Contacts